http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9627585-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_478bc336c8db1c573057b06be3adf320 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f98bd0461075af1947f06fb898be560 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C327-32 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C323-59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C327-32 |
| filingDate | 1996-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df3602713135e9ed25c031ca8b2748e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b46b4387cdd1979e376c6c6d735d8770 |
| publicationDate | 1996-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-9627585-A1 |
| titleOfInvention | Novel amino acid derivatives having n,n-dialkylaminophenyl group |
| abstract | Novel amino acid derivatives having an N,N-dialkylaminophenyl group represented by general formula (I), wherein R1 represents hydrogen, lower alkyl, phenyl lower alkyl, lower alkanoyl or benzoyl, provided that the phenyl ring in the phenyl lower alkyl or benzoyl may be substituted by halogeno, lower alkyl or lower alkoxy; R2 represents carboxyl optionally converted into ester, amide or hydroxamic acid; R3 represents lower alkyl; R4 represents lower alkyl; A1 represents lower alkylene optionally substituted by phenyl, provided that the phenyl group may be substituted by halogeno, lower alkyl or lower alkoxy; A2 represents lower alkylene; A3 represents lower alkylene; and Z represents S or O. The compounds have inhibitory effects on LTA and hydrolase and are useful as a drug, in particular, a remedy for diseases in which LTB¿4? participates such as rheumatism, psoriasis, inflammatory intestinal diseases, gout, cystic fibrosis, etc. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005027886-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7851486-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7507531-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005027886-A3 |
| priorityDate | 1995-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240 |
Total number of triples: 24.